Triston Smith, MD
Interventional Cardiology · Saint Clairsville, OHNPI 1376851519
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (28.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Edwards Lifesciences at 36.4% of the total. Reporting peaked in 2021 at $17,376 and has fallen 67.3% since, to $5,675 in 2025.
Across 546 payments — averaging $107.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$21K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$11K
- Abbott$10K
- Cardiovascular Systems Inc.$5K
- Boston Scientific$2K
- Biotronik Inc.$2K
- plus $7K from 31 others
Across 3 payments — averaging $22.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$66
What the payments were for
- Consulting fees$12,60021%
- Speaking & faculty fees$14,50025%
- Travel & lodging$14,65025%
- Food & beverage$16,78629%
- Education$3451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 119 | $21,418 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 62 | $11,059 |
| Abbott | 108 | $10,411 |
| Cardiovascular Systems Inc. | 16 | $4,663 |
| Boston Scientific | 38 | $2,473 |
| Biotronik Inc. | 10 | $2,010 |
| Cordis US CORP. | 5 | $1,141 |
| Kestra Medical Technology Services, Inc. | 5 | $489 |
| Amgen | 18 | $412 |
| Medtronic(2 entities) | 9 | $398 |
| Actelion Pharmaceuticals US, Inc. | 22 | $377 |
| AstraZeneca | 18 | $369 |
| Abiomed | 7 | $349 |
| Recor Medical Inc | 2 | $320 |
| Pfizer | 16 | $318 |
| Impulse Dynamics (USA) Inc. | 2 | $284 |
| E.r. Squibb & Sons, L.L.C. | 15 | $239 |
| Boehringer Ingelheim | 4 | $232 |
| Novartis | 14 | $221 |
| Siemens Medical Solutions USA, Inc. | 4 | $217 |
| Cerus Corporation | 3 | $163 |
| Shockwave Medical, Inc | 2 | $155 |
| GE HealthCare | 1 | $154 |
| Johnson & Johnson | 10 | $143 |
| Merck | 8 | $136 |
| Biosense Webster, Inc. | 1 | $135 |
| EKOS Corporation | 1 | $134 |
| Bayer | 3 | $97 |
| Sanofi-aventis U.S. LLC | 6 | $82 |
| Amarin Pharma, Inc. | 5 | $79 |
| Regeneron Healthcare Solutions, Inc. | 4 | $53 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Cardiva Medical, Inc. | 1 | $31 |
| Chiesi USA, Inc. | 2 | $24 |
| Portola Pharmaceuticals, LLC | 1 | $24 |
| Getinge USA Sales, LLC | 1 | $18 |
| W. L. Gore & Associates, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$16,525
- LifeVest$10,000
- Coronary Orbital Atherectomy System$4,500
- AMPLATZER AMULET$2,553
- GENERAL - THERAPIES$1,318
- TRICLIP$1,242
- Mitra Clip system$992
- ACCENT$984
- ANGIOGUARD$899
- AMPLATZER$535
- ASSURITY$377
- Edwards SAPIEN XT Transcatheter Heart Valve$370
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$363
- ABSOLUTE PRO$355
- OPTIMIZER SMART SYSTEM$284
- Assure WCD$268
- Paradise Ultrasound Renal Denervation System$231
- GALLANT$206
- OPTIS$204
- MitraClip$180
How this compares
$58,881 in reported general payments places this provider in the 85th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 127 | $148,632 |
| EntrestoSacubitril/Valsartan | 59 | $58,870 |
| XareltoRivaroxaban | 43 | $39,759 |
| BrilintaTicagrelor | 45 | $30,001 |
| JardianceEmpagliflozin | 22 | $22,709 |
| Repatha SureclickEvolocumab | 32 | $20,243 |
| MultaqDronedarone Hcl | 11 | $15,907 |
| Ranolazine ErRanolazine | 65 | $10,229 |
| Flecainide Acetate | 76 | $4,432 |
| Metoprolol Succinate | 289 | $3,155 |
| ClopidogrelClopidogrel Bisulfate | 215 | $2,618 |
| Atorvastatin Calcium | 219 | $2,445 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 153 | $1,945 |
| Amiodarone Hcl | 50 | $1,462 |
| Potassium Chloride | 43 | $1,204 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $318 | $148,632127 claims |
| NovartisEntresto | $221 | $58,87059 claims |
| Johnson & JohnsonXarelto | $143 | $39,75943 claims |
| AstraZenecaBrilinta | $369 | $30,00145 claims |
| Boehringer IngelheimJardiance | $232 | $22,70922 claims |
| Sanofi-aventis U.S. LLCMultaq | $82 | $15,90711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Saint Clairsville
- Gregory Suero AbreuSaint Clairsville$26K
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Timothy HenryCincinnati$605K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- John CorlCincinnati$390K
- Santiago GarciaCincinnati$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.